Abstract
Aside from gastroesophageal reflux disease and eosinophilic esophagitis, various other inflammatory and congenital disorders can affect the esophagus. This chapter discusses this wide variety of esophageal abnormalities and highlights their characteristic pathologic features. The most common of these abnormalities are infectious and treatment/drug-induced disorders—both are very frequently encountered by the practicing surgical pathologist and can have pathognomonic histologic features, which can be supported by special studies (e.g., fungal and viral infections). Other conditions such as congenital/developmental disorders are less frequently encountered in practice but are also well described here. Some histologic patterns of injuries, such as lymphocytic esophagitis and esophagitis dissecans superficialis, are rather unique and can be associated with a number of clinical conditions; the pathology of these lesions is detailed here. Further, the esophagus can sometimes get involved in systemic inflammatory and autoimmune conditions, including those primarily affecting the gastrointestinal tract (Crohn’s disease) or the skin (e.g., lichen planus). This chapter also discusses mechanical and corrosive esophageal injuries, as well as esophageal achalasia, an esophageal motility disorder characterized by incomplete lower esophageal sphincter relaxation, which results in increased lower esophageal sphincter tone and lack of peristalsis of the esophagus. Finally, pathological features of other benign lesions such as hyperplastic polyps, squamous papilloma, glycogenic acanthosis, and other miscellaneous conditions are also discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abraham SC, Cruz-Correa M, Lee LA, Yardley JH, Wu TT. Alendronate-associated esophageal injury: pathologic and endoscopic features. Mod Pathol. 1999;12(12):1152–7.
Abraham SC, Yardley JH, Wu TT. Erosive injury to the upper gastrointestinal tract in patients receiving iron medication: an underrecognized entity. Am J Surg Pathol. 1999;23(10):1241–7.
Bott S, Prakash C, McCallum RW. Medication-induced esophageal injury: survey of the literature. Am J Gastroenterol. 1987;82(8):758–63.
Boyce HW Jr. Drug-induced esophageal damage: diseases of medical progress. Gastrointest Endosc. 1998;47(6):547–50.
Kikendall JW, Friedman AC, Oyewole MA, Fleischer D, Johnson LF. Pill-induced esophageal injury. Case reports and review of the medical literature. Dig Dis Sci. 1983;28(2):174–82.
Semble EL, Wu WC, Castell DO. Nonsteroidal antiinflammatory drugs and esophageal injury. Semin Arthritis Rheum. 1989;19(2):99–109.
Taha AS, Dahill S, Nakshabendi I, Lee FD, Sturrock RD, Russell RI. Oesophageal histology in long term users of non-steroidal anti-inflammatory drugs. J Clin Pathol. 1994;47(8):705–8.
Parfitt JR, Driman DK. Pathological effects of drugs on the gastrointestinal tract: a review. Hum Pathol. 2007;38(4):527–36. https://doi.org/10.1016/j.humpath.2007.01.014.
Lewis JH. Gastrointestinal injury due to medicinal agents. Am J Gastroenterol. 1986;81(9):819–34.
Kaye P, Abdulla K, Wood J, James P, Foley S, Ragunath K, et al. Iron-induced mucosal pathology of the upper gastrointestinal tract: a common finding in patients on oral iron therapy. Histopathology. 2008;53(3):311–7. https://doi.org/10.1111/j.1365-2559.2008.03081.x.
Haig A, Driman DK. Iron-induced mucosal injury to the upper gastrointestinal tract. Histopathology. 2006;48(7):808–12. https://doi.org/10.1111/j.1365-2559.2006.02448.x.
Abraham SC, Bhagavan BS, Lee LA, Rashid A, Wu TT. Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. Am J Surg Pathol. 2001;25(5):637–44.
Gaduputi V, Tariq H, Ihimoyan A. A rare cause of esophagitis with crystal deposition. Can J Gastroenterol Hepatol. 2015;29(3):123–4.
Swanson BJ, Limketkai BN, Liu TC, Montgomery E, Nazari K, Park JY, et al. Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury. Am J Surg Pathol. 2013;37(11):1686–93. https://doi.org/10.1097/PAS.0b013e3182999d8d.
Stemmermann GN, Hayashi T. Colchicine intoxication. A reappraisal of its pathology based on a study of three fatal cases. Hum Pathol. 1971;2(2):321–32.
Iacobuzio-Donahue CA, Lee EL, Abraham SC, Yardley JH, Wu TT. Colchicine toxicity: distinct morphologic findings in gastrointestinal biopsies. Am J Surg Pathol. 2001;25(8):1067–73.
Daniels JA, Gibson MK, Xu L, Sun S, Canto MI, Heath E, et al. Gastrointestinal tract epithelial changes associated with taxanes: marker of drug toxicity versus effect. Am J Surg Pathol. 2008;32(3):473–7. https://doi.org/10.1097/PAS.0b013e3181582331.
Hruban RH, Yardley JH, Donehower RC, Boitnott JK. Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest. Cancer. 1989;63(10):1944–50.
Novak JM, Collins JT, Donowitz M, Farman J, Sheahan DG, Spiro HM. Effects of radiation on the human gastrointestinal tract. J Clin Gastroenterol. 1979;1(1):9–39.
Trowers E, Thomas C Jr, Silverstein FE. Chemical- and radiation-induced esophageal injury. Gastrointest Endosc Clin N Am. 1994;4(4):657–75.
Davila M, Bresalier RS. Gastrointestinal complications of oncologic therapy. Nat Clin Pract Gastroenterol Hepatol. 2008;5(12):682–96. https://doi.org/10.1038/ncpgasthep1277.
Maguire PD, Sibley GS, Zhou SM, Jamieson TA, Light KL, Antoine PA, et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys. 1999;45(1):97–103.
Choy H, LaPorte K, Knill-Selby E, Mohr P, Shyr Y. Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. Semin Radiat Oncol. 1999;9(2 Suppl 1):90–6.
Qiao WB, Zhao YH, Zhao YB, Wang RZ. Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity. World J Gastroenterol. 2005;11(17):2626–9.
O’Rourke IC, Tiver K, Bull C, Gebski V, Langlands AO. Swallowing performance after radiation therapy for carcinoma of the esophagus. Cancer. 1988;61(10):2022–6.
Coia LR, Myerson RJ, Tepper JE. Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys. 1995;31(5):1213–36. https://doi.org/10.1016/0360-3016(94)00419-L.
Rubio CA, Sjodahl K, Lagergren J. Lymphocytic esophagitis: a histologic subset of chronic esophagitis. Am J Clin Pathol. 2006;125(3):432–7.
Purdy JK, Appelman HD, Golembeski CP, McKenna BJ. Lymphocytic esophagitis: a chronic or recurring pattern of esophagitis resembling allergic contact dermatitis. Am J Clin Pathol. 2008;130(4):508–13. https://doi.org/10.1309/D3PCF6D6YYMQRX9A.
Haque S, Genta RM. Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition. Gut. 2012;61(8):1108–14. https://doi.org/10.1136/gutjnl-2011-301014.
Cohen S, Saxena A, Waljee AK, Piraka C, Purdy J, Appelman H, et al. Lymphocytic esophagitis: a diagnosis of increasing frequency. J Clin Gastroenterol. 2012;46(10):828–32. https://doi.org/10.1097/MCG.0b013e3182500de8.
Kasirye Y, John A, Rall C, Resnick J. Lymphocytic esophagitis presenting as chronic dysphagia. Clin Med Res. 2012;10(2):83–4. https://doi.org/10.3121/cmr.2011.1009.
Isolauri J, Markkula H. Lye ingestion and carcinoma of the esophagus. Acta Chir Scand. 1989;155(4–5):269–71.
de Jong AL, Macdonald R, Ein S, Forte V, Turner A. Corrosive esophagitis in children: a 30-year review. Int J Pediatr Otorhinolaryngol. 2001;57(3):203–11.
Garcia Diaz E, Castro Fernandez M, Romero Gomez M, Castilla Higuero L. Upper gastrointestinal tract injury caused by ingestion of caustic substances. Gastroenterol Hepatol. 2001;24(4):191–5.
Ein SH, Shandling B, Stephens CA. Twenty-one year experience with the pediatric gastric tube. J Pediatr Surg. 1987;22(1):77–81.
Friedman EM. Caustic ingestions and foreign bodies in the aerodigestive tract of children. Pediatr Clin N Am. 1989;36(6):1403–10.
Appelqvist P, Salmo M. Lye corrosion carcinoma of the esophagus: a review of 63 cases. Cancer. 1980;45(10):2655–8.
Cesar WG, Barrios MM, Maruta CW, Aoki V, Santi GG. Oesophagitis dissecans superficialis: an acute, benign phenomenon associated with pemphigus vulgaris. Clin Exp Dermatol. 2009;34(8):e614–6. https://doi.org/10.1111/j.1365-2230.2009.03308.x.
Carmack SW, Vemulapalli R, Spechler SJ, Genta RM. Esophagitis dissecans superficialis (“sloughing esophagitis”): a clinicopathologic study of 12 cases. Am J Surg Pathol. 2009;33(12):1789–94. https://doi.org/10.1097/PAS.0b013e3181b7ce21.
Hokama A, Ihama Y, Nakamoto M, Kinjo N, Kinjo F, Fujita J. Esophagitis dissecans superficialis associated with bisphosphonates. Endoscopy. 2007;39(Suppl 1):E91. https://doi.org/10.1055/s-2006-945146.
Hage-Nassar G, Rotterdam H, Frank D, Green PH. Esophagitis dissecans superficialis associated with celiac disease. Gastrointest Endosc. 2003;57(1):140–1. https://doi.org/10.1067/mge.2003.42.
Hokama A, Yamamoto Y, Taira K, Nakamura M, Kobashigawa C, Nakamoto M, et al. Esophagitis dissecans superficialis and autoimmune bullous dermatoses: a review. World J Gastrointest Endosc. 2010;2(7):252–6. https://doi.org/10.4253/wjge.v2.i7.252.
Purdy JK, Appelman HD, McKenna BJ. Sloughing esophagitis is associated with chronic debilitation and medications that injure the esophageal mucosa. Mod Pathol. 2012;25(5):767–75. https://doi.org/10.1038/modpathol.2011.204.
Beck RN. Oesophagitis dissecans superficialis. Br Med J. 1954;1(4860):501–2.
Ponsot P, Molas G, Scoazec JY, Ruszniewski P, Henin D, Bernades P. Chronic esophagitis dissecans: an unrecognized clinicopathologic entity? Gastrointest Endosc. 1997;45(1):38–45.
Stanley JR, Amagai M. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med. 2006;355(17):1800–10. https://doi.org/10.1056/NEJMra061111.
Montgobert J, Bellaiche G, Nouts A, Ley G, Slama JL. Transmural esophageal dissection after iatrogenic perforation of esophagitis dissecans visualized by thoracic x-ray computed tomography. Gastroenterol Clin Biol. 1999;23(8–9):987–8.
Ramaswami G, Jain PK, Talati VR. Oesophagitis dissecans superficialis complicating repeated rigid oesophagoscopy and dilatation. J Laryngol Otol. 2007;121(1):92–3. https://doi.org/10.1017/S002221510600274X.
Baehr PH, McDonald GB. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology. 1994;106(2):509–32.
Canalejo Castrillero E, Garcia Duran F, Cabello N, Garcia Martinez J. Herpes esophagitis in healthy adults and adolescents: report of 3 cases and review of the literature. Medicine (Baltimore). 2010;89(4):204–10. https://doi.org/10.1097/MD.0b013e3181e949ed.
McBane RD, Gross JB Jr. Herpes esophagitis: clinical syndrome, endoscopic appearance, and diagnosis in 23 patients. Gastrointest Endosc. 1991;37(6):600–3.
Buss DH, Scharyj M. Herpesvirus infection of the esophagus and other visceral organs in adults. Incidence and clinical significance. Am J Med. 1979;66(3):457–62.
McDonald GB, Sharma P, Hackman RC, Meyers JD, Thomas ED. Esophageal infections in immunosuppressed patients after marrow transplantation. Gastroenterology. 1985;88(5 Pt 1):1111–7.
Greenson JK, Beschorner WE, Boitnott JK, Yardley JH. Prominent mononuclear cell infiltrate is characteristic of herpes esophagitis. Hum Pathol. 1991;22(6):541–9.
Chetty R, Roskell DE. Cytomegalovirus infection in the gastrointestinal tract. J Clin Pathol. 1994;47(11):968–72.
Wang HW, Kuo CJ, Lin WR, Hsu CM, Ho YP, Lin CJ, et al. The clinical characteristics and manifestations of cytomegalovirus esophagitis. Dis Esophagus. 2016;29(4):392–9. https://doi.org/10.1111/dote.12340.
Griffiths PD, Grundy JE. The status of CMV as a human pathogen. Epidemiol Infect. 1988;100(1):1–15.
Bonacini M, Young T, Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. Arch Intern Med. 1991;151(8):1567–72.
Wilcox CM, Straub RF, Schwartz DA. Prospective endoscopic characterization of cytomegalovirus esophagitis in AIDS. Gastrointest Endosc. 1994;40(4):481–4.
Lemonovich TL, Watkins RR. Update on cytomegalovirus infections of the gastrointestinal system in solid organ transplant recipients. Curr Infect Dis Rep. 2012;14(1):33–40. https://doi.org/10.1007/s11908-011-0224-6.
Whitley RJ, Jacobson MA, Friedberg DN, Holland GN, Jabs DA, Dieterich DT, et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med. 1998;158(9):957–69.
Greenson JK. Macrophage aggregates in cytomegalovirus esophagitis. Hum Pathol. 1997;28(3):375–8.
Teot LA, Ducatman BS, Geisinger KR. Cytologic diagnosis of cytomegaloviral esophagitis. A report of three acquired immunodeficiency syndrome-related cases. Acta Cytol. 1993;37(1):93–6.
Samonis G, Skordilis P, Maraki S, Datseris G, Toloudis P, Chatzinikolaou I, et al. Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer. Clin Infect Dis. 1998;27(2):283–6.
Kodsi BE, Wickremesinghe C, Kozinn PJ, Iswara K, Goldberg PK. Candida esophagitis: a prospective study of 27 cases. Gastroenterology. 1976;71(5):715–9.
Simon MR, Houser WL, Smith KA, Long PM. Esophageal candidiasis as a complication of inhaled corticosteroids. Ann Allergy Asthma Immunol. 1997;79(4):333–8. https://doi.org/10.1016/S1081-1206(10)63024-4.
Larner AJ, Lendrum R. Oesophageal candidiasis after omeprazole therapy. Gut. 1992;33(6):860–1.
Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38(2):161–89. https://doi.org/10.1086/380796.
Barbaro G, Barbarini G, Calderon W, Grisorio B, Alcini P, Di Lorenzo G. Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis. Gastroenterology. 1996;111(5):1169–77.
Wagner C, Graninger W, Presterl E, Joukhadar C. The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology. 2006;78(4):161–77. https://doi.org/10.1159/000096348.
Arathoon EG, Gotuzzo E, Noriega LM, Berman RS, DiNubile MJ, Sable CA. Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother. 2002;46(2):451–7.
Mathieson R, Dutta SK. Candida esophagitis. Dig Dis Sci. 1983;28(4):365–70.
Gornig M, Emmert-Buck M, Walsh TJ. Patterns of Candida esophagitis in cancer and AIDS patients: histopathological study of 23 patients. Mycoses. 1997;40(Suppl 1):81–5.
Bertoni G, Sassatelli R, Nigrisoli E, Conigliaro R, Bedogni G. Ectopic sebaceous glands in the esophagus: report of three new cases and review of the literature. Am J Gastroenterol. 1994;89(10):1884–7.
Rywlin AM, Ortega R. Glycogenic acanthosis of the esophagus. Arch Pathol. 1970;90(5):439–43.
Bender MD, Allison J, Cuartas F, Montgomery C. Glycogenic acanthosis of the esophagus: a form of benign epithelial hyperplasia. Gastroenterology. 1973;65(3):373–80.
Maguire A, Sheahan K. Pathology of oesophagitis. Histopathology. 2012;60(6):864–79. https://doi.org/10.1111/j.1365-2559.2011.03855.x.
Ezzell JH Jr, Bremer J, Adamec TA. Bacterial esophagitis: an often forgotten cause of odynophagia. Am J Gastroenterol. 1990;85(3):296–8.
Walsh TJ, Belitsos NJ, Hamilton SR. Bacterial esophagitis in immunocompromised patients. Arch Intern Med. 1986;146(7):1345–8.
Forsmark CE, Wilcox CM, Darragh TM, Cello JP. Disseminated histoplasmosis in AIDS: an unusual case of esophageal involvement and gastrointestinal bleeding. Gastrointest Endosc. 1990;36(6):604–5.
Eng J, Sabanathan S. Tuberculosis of the esophagus. Dig Dis Sci. 1991;36(4):536–40.
Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602. https://doi.org/10.1016/S0140-6736(16)31678-6.
Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375(9723):1388–402. https://doi.org/10.1016/S0140-6736(10)60061-X.
Prata A. Evolution of the clinical and epidemiological knowledge about Chagas disease 90 years after its discovery. Mem Inst Oswaldo Cruz. 1999;94(Suppl 1):81–8.
Schmunis GA. Prevention of transfusional Trypanosoma cruzi infection in Latin America. Mem Inst Oswaldo Cruz. 1999;94(Suppl 1):93–101.
Rassi A Jr, Rassi A. Marcondes de Rezende J. American trypanosomiasis (Chagas disease). Infect Dis Clin N Am. 2012;26(2):275–91. https://doi.org/10.1016/j.idc.2012.03.002.
Teixeira AR, Hecht MM, Guimaro MC, Sousa AO, Nitz N. Pathogenesis of Chagas’ disease: parasite persistence and autoimmunity. Clin Microbiol Rev. 2011;24(3):592–630. https://doi.org/10.1128/CMR.00063-10.
Nascimento RD, de Souza Lisboa A, Fujiwara RT, de Freitas MA, Adad SJ, Oliveira RC, et al. Characterization of enteroglial cells and denervation process in chagasic patients with and without megaesophagus. Hum Pathol. 2010;41(4):528–34. https://doi.org/10.1016/j.humpath.2009.05.018.
Coura JR, Borges-Pereira J. Chagas disease. What is known and what should be improved: a systemic review. Rev Soc Bras Med Trop. 2012;45(3):286–96.
de Oliveira RB, Troncon LE, Dantas RO, Menghelli UG. Gastrointestinal manifestations of Chagas’ disease. Am J Gastroenterol. 1998;93(6):884–9. https://doi.org/10.1111/j.1572-0241.1998.270_r.x.
de Oliveira RB, Rezende Filho J, Dantas RO, Iazigi N. The spectrum of esophageal motor disorders in Chagas’ disease. Am J Gastroenterol. 1995;90(7):1119–24.
Dantas RO, Godoy RA, Oliveira RB, Meneghelli UG, Troncon LE. Lower esophageal sphincter pressure in Chagas’ disease. Dig Dis Sci. 1990;35(4):508–12.
Coura JR, Borges-Pereira J. Chronic phase of Chagas disease: why should it be treated? A comprehensive review. Mem Inst Oswaldo Cruz. 2011;106(6):641–5.
Coura JR. Present situation and new strategies for Chagas disease chemotherapy: a proposal. Mem Inst Oswaldo Cruz. 2009;104(4):549–54.
Coura JR. Current prospects of specific treatment of Chagas’ disease. Bol Chil Parasitol. 1996;51(3–4):69–75.
Koberle F. Chagas’ disease and Chagas’ syndromes: the pathology of American trypanosomiasis. Adv Parasitol. 1968;6:63–116.
Koberle F. The causation and importance of nervous lesions in American trypanosomiasis. Bull World Health Organ. 1970;42(5):739–43.
Decker GA, Loftus EV Jr, Pasha TM, Tremaine WJ, Sandborn WJ. Crohn’s disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis. 2001;7(2):113–9.
D’Haens G, Rutgeerts P, Geboes K, Vantrappen G. The natural history of esophageal Crohn’s disease: three patterns of evolution. Gastrointest Endosc. 1994;40(3):296–300.
De Felice KM, Katzka DA, Raffals LE. Crohn’s disease of the esophagus: clinical features and treatment outcomes in the biologic era. Inflamm Bowel Dis. 2015;21(9):2106–13. https://doi.org/10.1097/MIB.0000000000000469.
Ramaswamy K, Jacobson K, Jevon G, Israel D. Esophageal Crohn disease in children: a clinical spectrum. J Pediatr Gastroenterol Nutr. 2003;36(4):454–8.
Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA. Clinical aspects of Crohn’s disease of the upper gastrointestinal tract: a comparison with distal Crohn’s disease. Am J Gastroenterol. 1997;92(9):1467–71.
Estrada CA, Lewandowski C, Schubert TT, Dorman PJ. Esophageal involvement in secondary amyloidosis mimicking achalasia. J Clin Gastroenterol. 1990;12(4):447–50.
Rose S, Young MA, Reynolds JC. Gastrointestinal manifestations of scleroderma. Gastroenterol Clin N Am. 1998;27(3):563–94.
Lopez-Cepero Andrada JM, Jimenez Arjona J, Amaya Vidal A, Rubio Garrido J, Navas Relinque C, Soria de la Cruz MJ, et al. Pseudoachalasia and secondary amyloidosis in a patient with rheumatoid arthritis. Gastroenterol Hepatol. 2002;25(6):398–400.
Chua S, Dodd H, Saeed IT, Chakravarty K. Dysphagia in a patient with lupus and review of the literature. Lupus. 2002;11(5):322–4. https://doi.org/10.1191/0961203302lu195cr.
de Merieux P, Verity MA, Clements PJ, Paulus HE. Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis. Arthritis Rheum. 1983;26(8):961–8.
Fitzgerald RC, Triadafilopoulos G. Esophageal manifestations of rheumatic disorders. Semin Arthritis Rheum. 1997;26(4):641–66.
Palma R, Freire A, Freitas J, Morbey A, Costa T, Saraiva F, et al. Esophageal motility disorders in patients with Sjogren’s syndrome. Dig Dis Sci. 1994;39(4):758–61.
Cozzi F, Zucchetta P, Durigon N, Marzola MC, Bullo A, Favaro M, et al. Changes in esophageal peristalsis in diverse clinical forms and antibody specificity in scleroderma: a scintigraphic study in 100 cases. Reumatismo. 2003;55(2):86–92.
Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol. 1998;93(7):1085–9. https://doi.org/10.1111/j.1572-0241.1998.00334.x.
Recht MP, Levine MS, Katzka DA, Reynolds JC, Saul SH. Barrett’s esophagus in scleroderma: increased prevalence and radiographic findings. Gastrointest Radiol. 1988;13(1):1–5. https://doi.org/10.1007/BF01889012.
Katzka DA, Reynolds JC, Saul SH, Plotkin A, Lang CA, Ouyang A, et al. Barrett’s metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med. 1987;82(1):46–52.
Bargon J, Stein J, Dietrich CF, Muller U, Caspary WF, Wagner TO. Gastrointestinal complications of adult patients with cystic fibrosis. Z Gastroenterol. 1999;37(8):739–49.
Pauwels A, Blondeau K, Dupont LJ, Sifrim D. Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis. Am J Gastroenterol. 2012;107(9):1346–53. https://doi.org/10.1038/ajg.2012.213.
Dziekiewicz MA, Banaszkiewicz A, Urzykowska A, Lisowska A, Rachel M, Sands D, et al. Gastroesophageal reflux disease in children with cystic fibrosis. Adv Exp Med Biol. 2015;873:1–7. https://doi.org/10.1007/5584_2015_154.
Scott RB, O’Loughlin EV, Gall DG. Gastroesophageal reflux in patients with cystic fibrosis. J Pediatr. 1985;106(2):223–7.
Agrons GA, Corse WR, Markowitz RI, Suarez ES, Perry DR. Gastrointestinal manifestations of cystic fibrosis: radiologic-pathologic correlation. Radiographics. 1996;16(4):871–93. https://doi.org/10.1148/radiographics.16.4.8835977.
Hassall E, Israel DM, Davidson AG, Wong LT. Barrett’s esophagus in children with cystic fibrosis: not a coincidental association. Am J Gastroenterol. 1993;88(11):1934–8.
Blondeau K, Pauwels A, Dupont L, Mertens V, Proesmans M, Orel R, et al. Characteristics of gastroesophageal reflux and potential risk of gastric content aspiration in children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2010;50(2):161–6. https://doi.org/10.1097/MPG.0b013e3181acae98.
McDonald GB, Sullivan KM, Plumley TF. Radiographic features of esophageal involvement in chronic graft-vs.-host disease. AJR Am J Roentgenol. 1984;142(3):501–6. https://doi.org/10.2214/ajr.142.3.501.
Trabulo D, Ferreira S, Lage P, Rego RL, Teixeira G, Pereira AD. Esophageal stenosis with sloughing esophagitis: a curious manifestation of graft-vs-host disease. World J Gastroenterol. 2015;21(30):9217–22. https://doi.org/10.3748/wjg.v21.i30.9217.
Nakshabendi IM, Maldonado ME, Coppola D, Mamel JJ. Esophageal cast: a manifestation of graft-versus-host disease. Dig Dis. 2000;18(2):103–5. https://doi.org/10.1159/000016962.
Sodhi SS, Srinivasan R, Thomas RM. Esophageal graft versus host disease. Gastrointest Endosc. 2000;52(2):235. https://doi.org/10.1067/mge.2000.107289.
Otero Lopez-Cubero S, Sale GE, McDonald GB. Acute graft-versus-host disease of the esophagus. Endoscopy. 1997;29(7):S35–6.
Minocha A, Mandanas RA, Kida M, Jazzar A. Bullous esophagitis due to chronic graft-versus-host disease. Am J Gastroenterol. 1997;92(3):529–30.
Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology working group report. Biol Blood Marrow Transplant. 2006;12(1):31–47. https://doi.org/10.1016/j.bbmt.2005.10.023.
Lamireau T, Leaute-Labreze C, Le Bail B, Taieb A. Esophageal involvement in Stevens-Johnson syndrome. Endoscopy. 2001;33(6):550–3. https://doi.org/10.1055/s-2001-15091.
Wise JL, Murray JA. Esophageal manifestations of dermatologic disease. Curr Gastroenterol Rep. 2002;4(3):205–12.
Stewart MI, Woodley DT, Briggaman RA. Epidermolysis bullosa acquisita and associated symptomatic esophageal webs. Arch Dermatol. 1991;127(3):373–7.
Abraham SC, Ravich WJ, Anhalt GJ, Yardley JH, Wu TT. Esophageal lichen planus: case report and review of the literature. Am J Surg Pathol. 2000;24(12):1678–82.
Bobadilla J, van der Hulst RW, ten Kate FJ, Tytgat GN. Esophageal lichen planus. Gastrointest Endosc. 1999;50(2):268–71.
Jobard-Drobacheff C, Blanc D, Quencez E, Zultak M, Paris B, Ottignon Y, et al. Lichen planus of the oesophagus. Clin Exp Dermatol. 1988;13(1):38–41.
Leyva-Leon F, Wright AL, Wight RG, Harrington CI. Esophageal lichen planus presenting with dysphagia. Int J Dermatol. 1990;29(5):354–5.
Kirsch M. Esophageal lichen planus: a forgotten diagnosis. J Clin Gastroenterol. 1995;20(2):145–6.
Van Maercke P, Gunther M, Groth W, Gheorghiu T, Habermann U. Lichen ruber mucosae with esophageal involvement. Endoscopy. 1988;20(4):158–60. https://doi.org/10.1055/s-2007-1018165.
Chandan VS, Murray JA, Abraham SC. Esophageal lichen planus. Arch Pathol Lab Med. 2008;132(6):1026–9. https://doi.org/10.1043/1543-2165(2008)132[1026:ELP]2.0.CO;2.
Torzecka JD, Sysa-Jedrzejowska A, Waszczykowska E, Wozniacka A, Dziankowska-Bartkowiak B, Narbutt J. Immunopathological examination of esophagus as a useful criterion of cure in pemphigus vulgaris. J Eur Acad Dermatol Venereol. 1999;12(2):115–8.
Bernard P, Souyri N, Pillegand B, Bonnetblanc JM. Immunofluorescent studies of gastrointestinal tract mucosa in bullous pemphigoid. Arch Dermatol. 1986;122(2):137–8.
Gomi H, Akiyama M, Yakabi K, Nakamura T, Matsuo I. Oesophageal involvement in pemphigus vulgaris. Lancet. 1999;354(9192):1794. https://doi.org/10.1016/S0140-6736(99)04708-X.
Trattner A, Lurie R, Leiser A, David M, Hazaz B, Kadish U, et al. Esophageal involvement in pemphigus vulgaris: a clinical, histologic, and immunopathologic study. J Am Acad Dermatol. 1991;24(2 Pt 1):223–6.
Sharon P, Greene ML, Rachmilewitz D. Esophageal involvement in bullous pemphigoid. Gastrointest Endosc. 1978;24(3):122–3.
Ahmed AR, Hombal SM. Cicatricial pemphigoid. Int J Dermatol. 1986;25(2):90–6.
Epstein EH Jr. Molecular genetics of epidermolysis bullosa. Science. 1992;256(5058):799–804.
Shields HM, Shaffer K, O’Farrell RP, Travers R, Hayward JN, Becker LS, et al. Gastrointestinal manifestations of dermatologic disorders. Clin Gastroenterol Hepatol. 2007;5(9):1010–7; quiz 05–6. https://doi.org/10.1016/j.cgh.2007.05.018.
Travis SP, McGrath JA, Turnbull AJ, Schofield OM, Chan O, O’Connor AF, et al. Oral and gastrointestinal manifestations of epidermolysis bullosa. Lancet. 1992;340(8834–8835):1505–6.
Ergun GA, Lin AN, Dannenberg AJ, Carter DM. Gastrointestinal manifestations of epidermolysis bullosa. A study of 101 patients. Medicine (Baltimore). 1992;71(3):121–7.
Zweiban B, Cohen H, Chandrasoma P. Gastrointestinal involvement complicating Stevens-Johnson syndrome. Gastroenterology. 1986;91(2):469–74.
Mahe A, Keita S, Blanc L, Bobin P. Esophageal necrosis in the Stevens-Johnson syndrome. J Am Acad Dermatol. 1993;29(1):103–4.
Harewood GC, Murray JA, Cameron AJ. Esophageal lichen planus: the Mayo Clinic experience. Dis Esophagus. 1999;12(4):309–11.
Galloro G, Diamantis G, Magno L, Inzirillo M, Mignogna MC, Mignogna C, et al. Technical aspects in endoscopic biopsy of lesions in esophageal pemphigus vulgaris. Dig Liver Dis. 2007;39(4):363–7. https://doi.org/10.1016/j.dld.2006.12.008.
Lever WF. Pemphigus. Medicine (Baltimore). 1953;32(1):1–123.
Mignogna MD, Lo Muzio L, Galloro G, Satriano RA, Ruocco V, Bucci E. Oral pemphigus: clinical significance of esophageal involvement: report of eight cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84(2):179–84.
Park W, Vaezi MF. Etiology and pathogenesis of achalasia: the current understanding. Am J Gastroenterol. 2005;100(6):1404–14. https://doi.org/10.1111/j.1572-0241.2005.41775.x.
Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut. 2001;49(1):145–51.
Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA. 2015;313(18):1841–52. https://doi.org/10.1001/jama.2015.2996.
Farrokhi F, Vaezi MF. Idiopathic (primary) achalasia. Orphanet J Rare Dis. 2007;2:38. https://doi.org/10.1186/1750-1172-2-38.
Spiess AE, Kahrilas PJ. Treating achalasia: from whalebone to laparoscope. JAMA. 1998;280(7):638–42.
Lake JM, Wong RK. Review article: the management of achalasia—a comparison of different treatment modalities. Aliment Pharmacol Ther. 2006;24(6):909–18. https://doi.org/10.1111/j.1365-2036.2006.03079.x.
Dughera L, Cassolino P, Cisaro F, Chiaverina M. Achalasia. Minerva Gastroenterol Dietol. 2008;54(3):277–85.
Spechler SJ, Souza RF, Rosenberg SJ, Ruben RA, Goyal RK. Heartburn in patients with achalasia. Gut. 1995;37(3):305–8.
Ott DJ, Richter JE, Chen YM, Wu WC, Gelfand DW, Castell DO. Esophageal radiography and manometry: correlation in 172 patients with dysphagia. AJR Am J Roentgenol. 1987;149(2):307–11. https://doi.org/10.2214/ajr.149.2.307.
Omura N, Kashiwagi H, Yano F, Tsuboi K, Ishibashi Y, Hoshino M, et al. Effect of laparoscopic esophagomyotomy on chest pain associated with achalasia and prediction of therapeutic outcomes. Surg Endosc. 2011;25(4):1048–53. https://doi.org/10.1007/s00464-010-1314-5.
Sharp KW, Khaitan L, Scholz S, Holzman MD, Richards WO. 100 consecutive minimally invasive Heller myotomies: lessons learned. Ann Surg. 2002;235(5):631–8; discussion 8–9
Patti MG, Pellegrini CA, Horgan S, Arcerito M, Omelanczuk P, Tamburini A, et al. Minimally invasive surgery for achalasia: an 8-year experience with 168 patients. Ann Surg. 1999;230(4):587–93; discussion 93–4
Triadafilopoulos G, Aaronson M, Sackel S, Burakoff R. Medical treatment of esophageal achalasia. Double-blind crossover study with oral nifedipine, verapamil, and placebo. Dig Dis Sci. 1991;36(3):260–7.
Clark SB, Rice TW, Tubbs RR, Richter JE, Goldblum JR. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol. 2000;24(8):1153–8.
Goldblum JR, Whyte RI, Orringer MB, Appelman HD. Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol. 1994;18(4):327–37.
Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology. 1996;111(3):648–54.
Lehman MB, Clark SB, Ormsby AH, Rice TW, Richter JE, Goldblum JR. Squamous mucosal alterations in esophagectomy specimens from patients with end-stage achalasia. Am J Surg Pathol. 2001;25(11):1413–8.
Gockel I, Bohl JR, Doostkam S, Eckardt VF, Junginger T. Spectrum of histopathologic findings in patients with achalasia reflects different etiologies. J Gastroenterol Hepatol. 2006;21(4):727–33. https://doi.org/10.1111/j.1440-1746.2006.04250.x.
Kjellin AP, Ost AE, Pope CE 2nd. Histology of esophageal mucosa from patients with achalasia. Dis Esophagus. 2005;18(4):257–61. https://doi.org/10.1111/j.1442-2050.2005.00478.x.
Shoenut JP, Micflikier AB, Yaffe CS, Den Boer B, Teskey JM. Reflux in untreated achalasia patients. J Clin Gastroenterol. 1995;20(1):6–11.
Knauer CM. Mallory-Weiss syndrome. Characterization of 75 Mallory-Weiss lacerations in 528 patients with upper gastrointestinal hemorrhage. Gastroenterology. 1976;71(1):5–8.
Younes Z, Johnson DA. The spectrum of spontaneous and iatrogenic esophageal injury: perforations, Mallory-Weiss tears, and hematomas. J Clin Gastroenterol. 1999;29(4):306–17.
Caroli A, Follador R, Gobbi V, Breda P, Ricci G. Mallory-Weiss syndrome. Personal experience and review of the literature. Minerva Dietol Gastroenterol. 1989;35(1):7–12.
Dagradi AE, Broderick JT, Juler G, Wolinsky S, Stempien SJ. The Mallory-Weiss syndrome and lesion. A study of 30 cases. Am J Dig Dis. 1966;11(9):710–21.
Watts HD, Admirand WH. Mallory-Weiss syndrome. A reappraisal. JAMA. 1974;230(12):1674–5.
Yin A, Li Y, Jiang Y, Liu J, Luo H. Mallory-Weiss syndrome: clinical and endoscopic characteristics. Eur J Intern Med. 2012;23(4):e92–6. https://doi.org/10.1016/j.ejim.2012.02.005.
Parva M, Finnegan M, Keiter C, Mercogliano G, Perez CM. Mallory-Weiss tear diagnosed in the immediate postpartum period: a case report. J Obstet Gynaecol Can. 2009;31(8):740–3. https://doi.org/10.1016/S1701-2163(16)34280-3.
Lawrence DR, Ohri SK, Moxon RE, Townsend ER, Fountain SW. Primary esophageal repair for Boerhaave’s syndrome. Ann Thorac Surg. 1999;67(3):818–20.
Lawrence DR, Moxon RE, Fountain SW, Ohri SK, Townsend ER. Iatrogenic oesophageal perforations: a clinical review. Ann R Coll Surg Engl. 1998;80(2):115–8.
Woo KM, Schneider JI. High-risk chief complaints I: chest pain—the big three. Emerg Med Clin North Am. 2009;27(4):685–712, x. https://doi.org/10.1016/j.emc.2009.07.007.
Vial CM, Whyte RI. Boerhaave’s syndrome: diagnosis and treatment. Surg Clin North Am. 2005;85(3):515–24, ix. https://doi.org/10.1016/j.suc.2005.01.010.
de Lutio di Castelguidone E, Merola S, Pinto A, Raissaki M, Gagliardi N, Romano L. Esophageal injuries: spectrum of multidetector row CT findings. Eur J Radiol. 2006;59(3):344–8. https://doi.org/10.1016/j.ejrad.2006.04.027.
Gubbins GP, Nensey YM, Schubert TT, Batra SK. Barogenic perforation of the esophagus distal to a stricture after endoscopy. J Clin Gastroenterol. 1990;12(3):310–2.
de Schipper JP, Pull ter Gunne AF, Oostvogel HJ, van Laarhoven CJ. Spontaneous rupture of the oesophagus: Boerhaave’s syndrome in 2008. Literature review and treatment algorithm. Dig Surg. 2009;26(1):1–6. https://doi.org/10.1159/000191283.
Korn O, Onate JC, Lopez R. Anatomy of the Boerhaave syndrome. Surgery. 2007;141(2):222–8. https://doi.org/10.1016/j.surg.2006.06.034.
Tobin RW. Esophageal rings, webs, and diverticula. J Clin Gastroenterol. 1998;27(4):285–95.
Atmatzidis K, Papaziogas B, Pavlidis T, Mirelis C, Papaziogas T. Plummer-Vinson syndrome. Dis Esophagus. 2003;16(2):154–7.
Rice TW. Esophageal diverticula: introduction. Semin Thorac Cardiovasc Surg. 1999;11(4):325.
Reznik SI, Rice TW, Murthy SC, Mason DP, Apperson-Hansen C, Blackstone EH. Assessment of a pathophysiology-directed treatment for symptomatic epiphrenic diverticulum. Dis Esophagus. 2007;20(4):320–7. https://doi.org/10.1111/j.1442-2050.2007.00716.x.
Bhattacharya S, Mahmud S, McGlinchey I, Nassar AH. Intramural pseudodiverticulosis of the esophagus. Surg Endosc. 2002;16(4):714–5. https://doi.org/10.1007/s00464-001-4234-6.
Bruhlmann WF, Zollikofer CL, Maranta E, Hefti ML, Bivetti J, Giger M, et al. Intramural pseudodiverticulosis of the esophagus: report of seven cases and literature review. Gastrointest Radiol. 1981;6(3):199–208.
Sabanathan S, Salama FD, Morgan WE. Oesophageal intramural pseudodiverticulosis. Thorax. 1985;40(11):849–57.
Neumann WL, Lujan GM, Genta RM. Gastric heterotopia in the proximal oesophagus (“inlet patch”): association with adenocarcinomas arising in Barrett mucosa. Dig Liver Dis. 2012;44(4):292–6. https://doi.org/10.1016/j.dld.2011.11.008.
Yuksel I, Uskudar O, Koklu S, Basar O, Gultuna S, Unverdi S, et al. Inlet patch: associations with endoscopic findings in the upper gastrointestinal system. Scand J Gastroenterol. 2008;43(8):910–4.
Weickert U, Wolf A, Schroder C, Autschbach F, Vollmer H. Frequency, histopathological findings, and clinical significance of cervical heterotopic gastric mucosa (gastric inlet patch): a prospective study in 300 patients. Dis Esophagus. 2011;24(2):63–8. https://doi.org/10.1111/j.1442-2050.2010.01091.x.
Tang P, McKinley MJ, Sporrer M, Kahn E. Inlet patch: prevalence, histologic type, and association with esophagitis, Barrett esophagus, and antritis. Arch Pathol Lab Med. 2004;128(4):444–7. https://doi.org/10.1043/1543-2165(2004)128<444:IPPHTA>2.0.CO;2.
Terada T. Heterotopic gastric mucosa of the gastrointestinal tract: a histopathologic study of 158 cases. Pathol Res Pract. 2011;207(3):148–50. https://doi.org/10.1016/j.prp.2010.12.004.
Borhan-Manesh F, Farnum JB. Incidence of heterotopic gastric mucosa in the upper oesophagus. Gut. 1991;32(9):968–72.
Jabbari M, Goresky CA, Lough J, Yaffe C, Daly D, Cote C. The inlet patch: heterotopic gastric mucosa in the upper esophagus. Gastroenterology. 1985;89(2):352–6.
Azar C, Jamali F, Tamim H, Abdul-Baki H, Soweid A. Prevalence of endoscopically identified heterotopic gastric mucosa in the proximal esophagus: endoscopist dependent? J Clin Gastroenterol. 2007;41(5):468–71. https://doi.org/10.1097/01.mcg.0000225519.59030.8d.
Sanchez-Pernaute A, Hernando F, Diez-Valladares L, Gonzalez O, Perez Aguirre E, Furio V, et al. Heterotopic gastric mucosa in the upper esophagus (“inlet patch”): a rare cause of esophageal perforation. Am J Gastroenterol. 1999;94(10):3047–50. https://doi.org/10.1111/j.1572-0241.1999.01458.x.
Yarborough CS, McLane RC. Stricture related to an inlet patch of the esophagus. Am J Gastroenterol. 1993;88(2):275–6.
Chatelain D, de Lajarte-Thirouard AS, Tiret E, Flejou JF. Adenocarcinoma of the upper esophagus arising in heterotopic gastric mucosa: common pathogenesis with Barrett’s adenocarcinoma? Virchows Arch. 2002;441(4):406–11.
Alrawi SJ, Winston J, Tan D, Gibbs J, Loree TR, Hicks W, et al. Primary adenocarcinoma of cervical esophagus. J Exp Clin Cancer Res. 2005;24(2):325–30.
Gutierrez O, Akamatsu T, Cardona H, Graham DY, El-Zimaity HM. Helicobacter pylori and hetertopic gastric mucosa in the upper esophagus (the inlet patch). Am J Gastroenterol. 2003;98(6):1266–70. https://doi.org/10.1111/j.1572-0241.2003.07488.x.
Akbayir N, Alkim C, Erdem L, Sokmen HM, Sungun A, Basak T, et al. Heterotopic gastric mucosa in the cervical esophagus (inlet patch): endoscopic prevalence, histological and clinical characteristics. J Gastroenterol Hepatol. 2004;19(8):891–6. https://doi.org/10.1111/j.1440-1746.2004.03474.x.
Borhan-Manesh F, Farnum JB. Study of Helicobacter pylori colonization of patches of heterotopic gastric mucosa (HGM) at the upper esophagus. Dig Dis Sci. 1993;38(1):142–6.
Shah KK, DeRidder PH, Shah KK. Ectopic gastric mucosa in proximal esophagus. Its clinical significance and hormonal profile. J Clin Gastroenterol. 1986;8(5):509–13.
Jacobs E, Dehou MF. Heterotopic gastric mucosa in the upper esophagus: a prospective study of 33 cases and review of literature. Endoscopy. 1997;29(8):710–5. https://doi.org/10.1055/s-2007-1004294.
Gurvits GE, Shapsis A, Lau N, Gualtieri N, Robilotti JG. Acute esophageal necrosis: a rare syndrome. J Gastroenterol. 2007;42(1):29–38. https://doi.org/10.1007/s00535-006-1974-z.
Grudell AB, Mueller PS, Viggiano TR. Black esophagus: report of six cases and review of the literature, 1963–2003. Dis Esophagus. 2006;19(2):105–10. https://doi.org/10.1111/j.1442-2050.2006.00549.x.
Hong JW, Kim SU, Park HN, Seo JH, Lee YC, Kim H. Black esophagus associated with alcohol abuse. Gut Liver. 2008;2(2):133–5. https://doi.org/10.5009/gnl.2008.2.2.133.
Odelowo OO, Hassan M, Nidiry JJ, Marshalleck JJ. Acute necrotizing esophagitis: a case report. J Natl Med Assoc. 2002;94(8):735–7.
Endo T, Sakamoto J, Sato K, Takimoto M, Shimaya K, Mikami T, et al. Acute esophageal necrosis caused by alcohol abuse. World J Gastroenterol. 2005;11(35):5568–70.
Burtally A, Gregoire P. Acute esophageal necrosis and low-flow state. Can J Gastroenterol. 2007;21(4):245–7.
Lacy BE, Toor A, Bensen SP, Rothstein RI, Maheshwari Y. Acute esophageal necrosis: report of two cases and a review of the literature. Gastrointest Endosc. 1999;49(4 Pt 1):527–32.
Khan AM, Hundal R, Ramaswamy V, Korsten M, Dhuper S. Acute esophageal necrosis and liver pathology, a rare combination. World J Gastroenterol. 2004;10(16):2457–8.
Watermeyer GA, Shaw JM, Krige JE. Education and imaging. Gastrointestinal: acute necrotizing esophagitis. J Gastroenterol Hepatol. 2007;22(7):1162. https://doi.org/10.1111/j.1440-1746.2007.05013.x.
Day A, Sayegh M. Acute oesophageal necrosis: a case report and review of the literature. Int J Surg. 2010;8(1):6–14. https://doi.org/10.1016/j.ijsu.2009.09.014.
Luketic VA, Sanyal AJ. Esophageal varices. I. Clinical presentation, medical therapy, and endoscopic therapy. Gastroenterol Clin N Am. 2000;29(2):337–85.
de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001;5(3):645–63.
Ashkenazi E, Kovalev Y, Zuckerman E. Evaluation and treatment of esophageal varices in the cirrhotic patient. Isr Med Assoc J. 2013;15(2):109–15.
Arakawa M, Kage M. Haemorrhage in the upper digestive tract due to portal hypertension: clinicopathological examinations of the foci of haemorrhage. J Gastroenterol Hepatol. 1989;4(Suppl 1):168–70.
Evans DM, Jones DB, Cleary BK, Smith PM. Oesophageal varices treated by sclerotherapy: a histopathological study. Gut. 1982;23(7):615–20.
Vadva MD, Triadafilopoulos G. Glycogenic acanthosis of the esophagus and gastroesophageal reflux. J Clin Gastroenterol. 1993;17(1):79–83.
Kay PS, Soetikno RM, Mindelzun R, Young HS. Diffuse esophageal glycogenic acanthosis: an endoscopic marker of Cowden’s disease. Am J Gastroenterol. 1997;92(6):1038–40.
Glick SN, Teplick SK, Goldstein J, Stead JA, Zitomer N. Glycogenic acanthosis of the esophagus. AJR Am J Roentgenol. 1982;139(4):683–8. https://doi.org/10.2214/ajr.139.4.683.
Ghahremani GG, Rushovich AM. Glycogenic acanthosis of the esophagus: radiographic and pathologic features. Gastrointest Radiol. 1984;9(2):93–8.
Quitadamo M, Benson J. Squamous papilloma of the esophagus: a case report and review of the literature. Am J Gastroenterol. 1988;83(2):194–201.
Rabin MS, Bremner CG, Botha JR. The reflux gastroesophageal polyp. Am J Gastroenterol. 1980;73(5):451–2.
Long KB, Odze RD. Gastroesophageal junction hyperplastic (inflammatory) polyps: a clinical and pathologic study of 46 cases. Am J Surg Pathol. 2011;35(7):1038–44. https://doi.org/10.1097/PAS.0b013e3182189425.
Fernandez-Rodriguez CM, Badia-Figuerola N, Ruiz del Arbol L, Fernandez-Seara J, Dominguez F, Aviles-Ruiz JF. Squamous papilloma of the esophagus: report of six cases with long-term follow-up in four patients. Am J Gastroenterol. 1986;81(11):1059–62.
Abraham SC, Singh VK, Yardley JH, Wu TT. Hyperplastic polyps of the esophagus and esophagogastric junction: histologic and clinicopathologic findings. Am J Surg Pathol. 2001;25(9):1180–7.
De Ceglie A, Lapertosa G, Blanchi S, Di Muzio M, Picasso M, Filiberti R, et al. Endoscopic mucosal resection of large hyperplastic polyps in 3 patients with Barrett’s esophagus. World J Gastroenterol. 2006;12(35):5699–704.
Odze R, Antonioli D, Shocket D, Noble-Topham S, Goldman H, Upton M. Esophageal squamous papillomas. A clinicopathologic study of 38 lesions and analysis for human papillomavirus by the polymerase chain reaction. Am J Surg Pathol. 1993;17(8):803–12.
Yoo SS, Lee WH, Ha J, Choi SP, Kim HJ, Kim TH, et al. The prevalence of esophageal disorders in the subjects examined for health screening. Korean J Gastroenterol. 2007;50(5):306–12.
Bohn OL, Navarro L, Saldivar J, Sanchez-Sosa S. Identification of human papillomavirus in esophageal squamous papillomas. World J Gastroenterol. 2008;14(46):7107–11.
Carr NJ, Bratthauer GL, Lichy JH, Taubenberger JK, Monihan JM, Sobin LH. Squamous cell papillomas of the esophagus: a study of 23 lesions for human papillomavirus by in situ hybridization and the polymerase chain reaction. Hum Pathol. 1994;25(5):536–40.
Kato H, Orito E, Yoshinouchi T, Ueda R, Koizumi T, Yoshinouchi M, et al. Regression of esophageal papillomatous polyposis caused by high-risk type human papilloma virus. J Gastroenterol. 2003;38(6):579–83.
Attila T, Fu A, Gopinath N, Streutker CJ, Marcon NE. Esophageal papillomatosis complicated by squamous cell carcinoma. Can J Gastroenterol. 2009;23(6):415–9.
Van Cutsem E, Geboes K, Vantrappen G. Malignant degeneration of esophageal squamous papilloma associated with the human papillomavirus. Gastroenterology. 1992;103(3):1119–20.
Carr NJ, Monihan JM, Sobin LH. Squamous cell papilloma of the esophagus: a clinicopathologic and follow-up study of 25 cases. Am J Gastroenterol. 1994;89(2):245–8.
Szanto I, Szentirmay Z, Banai J, Nagy P, Gonda G, Voros A, et al. Squamous papilloma of the esophagus. Clinical and pathological observations based on 172 papillomas in 155 patients. Orv Hetil. 2005;146(12):547–52.
Politoske EJ. Squamous papilloma of the esophagus associated with the human papillomavirus. Gastroenterology. 1992;102(2):668–73.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mounajjed, T. (2019). Drug-induced Injury, Infections, and Congenital and Miscellaneous Disorders. In: Zhang, L., Chandan, V., Wu, TT. (eds) Surgical Pathology of Non-neoplastic Gastrointestinal Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-15573-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-15573-5_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-15572-8
Online ISBN: 978-3-030-15573-5
eBook Packages: MedicineMedicine (R0)